A5051897048- Tuberculosis Research and Epidemiology
- Pneumocystis jirovecii pneumonia detection and treatment
- Diagnosis and treatment of tuberculosis
- Pneumonia and Respiratory Infections
- Infectious Diseases and Tuberculosis
- Particle physics theoretical and experimental studies
- Quantum Chromodynamics and Particle Interactions
- High-Energy Particle Collisions Research
- Mycobacterium research and diagnosis
- SARS-CoV-2 detection and testing
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- COVID-19 diagnosis using AI
- HIV/AIDS drug development and treatment
- Nuclear physics research studies
- Health Systems, Economic Evaluations, Quality of Life
- COVID-19 epidemiological studies
- Respiratory viral infections research
- Biosimilars and Bioanalytical Methods
- HIV/AIDS Impact and Responses
- Particle accelerators and beam dynamics
- Migration, Health and Trauma
- Particle Detector Development and Performance
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Biosensors and Analytical Detection
McGill University Health Centre
2018-2025
McGill University
2016-2025
University of British Columbia
2014-2023
West Park Healthcare Centre
2023
University Health Network
2012-2023
University of Toronto
2016-2023
Respiratory Clinical Trials
2023
Peter Doherty Institute
2023
Imperial College London
1975-2022
Hospital for Tropical Diseases
2022
We sought to compare the effectiveness of two World Health Organization (WHO)-recommended regimens for treatment rifampin- or multidrug-resistant (RR/MDR) tuberculosis (TB): a standardised regimen 9–12 months (the “shorter regimen”) and individualised ≥20 (“longer regimens”). collected individual patient data from observational studies identified through systematic reviews public call data. included patients meeting WHO eligibility criteria shorter regimen: not previously treated with...
<h3>BACKGROUND:</h3> Testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is largely passive, which impedes epidemic control. We defined active testing strategies SARS-CoV-2 using reverse transcription polymerase chain reaction (RT-PCR) groups at increased risk of acquiring in all Canadian provinces. <h3>METHODS:</h3> identified 5 who should be prioritized RT-PCR testing: contacts people are positive SARS-CoV-2, and 4 at-risk populations — hospital employees, community...
Longitudinal mass testing using rapid antigen detection tests (RADT) for serial screening of asymptomatic persons has been proposed preventing SARS-CoV-2 community transmission. The feasibility this strategy relies on accurate self-testing.To quantify the adequacy self-performed RADT in workplace, terms frequency correct execution procedural steps and interpretation range possible results.This prospective repeated cross-sectional study was performed from July to October 2021 at businesses...
Abstract Background Tuberculosis (TB) incidence remains disproportionately high in people migrating to Canada and other low TB countries, but systematic screening prevention migrants is often cost-prohibitive for programs. We aimed develop validate a risk prediction model inform decisions foreign-born permanent residents of Canada. Methods developed validated proportional baselines landmark supermodel using health administrative data from British Columbia Ontario, two distinct provincial...